Cite
Chromone–lipoic acid conjugate: Neuroprotective agent having acceptable butyrylcholinesterase inhibition, antioxidant and copper-chelation activities.
MLA
Jalili-Baleh, Leili, et al. “Chromone–lipoic Acid Conjugate: Neuroprotective Agent Having Acceptable Butyrylcholinesterase Inhibition, Antioxidant and Copper-Chelation Activities.” DARU: Journal of Pharmaceutical Sciences, vol. 29, Jan. 2021, pp. 23–38. EBSCOhost, https://doi.org/10.1007/s40199-020-00378-1.
APA
Jalili-Baleh, L., Nadri, H., Forootanfar, H., Küçükkılınç, T. T., Ayazgök, B., Sharifzadeh, M., Rahimifard, M., Baeeri, M., Abdollahi, M., Foroumadi, A., & Khoobi, M. (2021). Chromone–lipoic acid conjugate: Neuroprotective agent having acceptable butyrylcholinesterase inhibition, antioxidant and copper-chelation activities. DARU: Journal of Pharmaceutical Sciences, 29, 23–38. https://doi.org/10.1007/s40199-020-00378-1
Chicago
Jalili-Baleh, Leili, Hamid Nadri, Hamid Forootanfar, Tuba Tüylü Küçükkılınç, Beyza Ayazgök, Mohammad Sharifzadeh, Mahban Rahimifard, et al. 2021. “Chromone–lipoic Acid Conjugate: Neuroprotective Agent Having Acceptable Butyrylcholinesterase Inhibition, Antioxidant and Copper-Chelation Activities.” DARU: Journal of Pharmaceutical Sciences 29 (January): 23–38. doi:10.1007/s40199-020-00378-1.